Literature DB >> 35187391

Timing for diagnosis and treatment in initially uncomplicated endocarditis: still a thorny issue.

Rita Pavasini1, Timothy C Tan2, Christoph Sinning3.   

Abstract

Entities:  

Year:  2021        PMID: 35187391      PMCID: PMC8852256          DOI: 10.1093/ehjcr/ytab348

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


× No keyword cloud information.
This editorial refers to ‘Acute posteromedial papillary muscle rupture secondary to aortic valve endocarditis: a case report’, by A. Marumoto Despite overall improvements in the general health condition of the global population and accessibility to health care in this modern era, infective endocarditis (IE) continues to remain a significant health issue. Global contemporary rates reflect a constant increase in the incidence and prevalence of IE. Furthermore, patients with IE are now typically older, have multiple cardiovascular comorbidities, and are more likely to have a biological or mechanical prosthesis, implanted devices, congenital heart disease, or long-term intravenous access for cancer treatment posing a challenge in treatment. Marumoto et al. describe a case of group G streptococcal endocarditis in an 81-year-old patient with a perforated aortic valve resulting in moderate aortic regurgitation. The patient was initially asymptomatic on presentation with no evidence of embolic phenomenon or cardiac decompensation. The patient was conservatively managed with intravenous antibiotics based on current guideline recommendations. After 7 days of treatment with penicillin G, the patient developed clinical signs of decompensated heart failure and was found to have acute significant mitral regurgitation secondary to a papillary muscle rupture. Interestingly, in this case there was no visual evidence of infection or vegetations on the mitral leaflets in the initial transoesophageal echocardiography (TOE). This case highlights how the clinical indication and need for surgery can evolve within a short period of time from a relatively benign course to an urgent need for surgical intervention (Class I, Level of evidence B). This case represents a common clinical scenario where the initial presentation relates to the presence of a leaflet perforation with no significant impact on the valve. Despite appropriate antibiotic therapy, ∼3% of stable patients with IE require unplanned surgery. Management of IE patients is further complicated by the challenges associated with infection of valve prostheses or concurrent intra-cardiac devices infections. These issues highlight a common conundrum associated with the management of valvular endocarditis, i.e. optimal timing for surgical intervention in IE. Unfortunately, there are presently no large randomized controlled trials available to answer this question, particularly in cases of seemingly uncomplicated IE. There are, however, four meta-analyses comparing early surgery with conventional medical treatment or late surgery, demonstrating an overall reduction in mortality in patients treated with early surgery (). However, the studies included in these meta-analyses were largely observational trials or from propensity-matched studies, hence the heterogeneity of the data is high. Furthermore, the definition of early surgery varied considerably in the studies included and the subgroups of patients (e.g. with native valves vs. prosthetic valves, right-sided endocarditis, microbiological aetiology) are not often clearly differentiated. Decision-making in a multidisciplinary endocarditis team may be the best course of action since this approach has been associated with a reduction of in-hospital and late mortality., Another question arising from the case presented by Marumoto et al. pertains to the mechanism underlying the acute rupture of the papillary muscle. In the featured case, it appears that first-line imaging, i.e. echocardiography was not adequate in elucidating the extent of the underlying tissue affected as demonstrated in this case. This issue is also highlighted by the case of Zogg et al. which shows how both transthoracic and TOE evaluation for IE in a severely calcified bicuspid valve was not sufficient to detect an extensive aortic root abscess. In this case report, the patient presented with streptococcus sanguinis bacteraemia and new-onset left bundle branch block that progressed to complete heart block. Transoesophageal echocardiography showed the presence of vegetations on the aortic valve but did not show any evidence of aortic root abscess. A correct diagnosis was made only by using 18F-fluorodesoxyglucose–positron emission tomography (18FDG–PET) imaging, which revealed the presence of focal activity around the aortic root suggestive for active infection of the aortic valve and possible abscess, which was subsequently confirmed by visual inspection of the aortic root during surgery.
Table 1

Meta-analyses about early surgery vs. late surgery or medical treatment in endocarditis

ReferencesYear of publicationNumber of studies includedPatients includedComparisonOutcomes
Jia et al.620178 for in-hospital mortality3940 patients for in-hospital mortalityEarly surgery was defined as surgery performed in active phase; in case the duration between surgery and entrance to hospital was not more than 4 weeks; or surgery performed during initial hospitalizationEarly surgery reduce in-hospital mortality, follow-up mortality, and IE-related mortality
6 for follow-up mortality840 patients for follow-up mortality
4 for IE-related mortality561 for IE-related mortality
Anantha Narayanan et al.7201621 studies11 048 patientsEarly surgery was defined at 20 days or less and conservative managementEarly surgical intervention is associated with significantly lower risk of mortality in patients with IE
Liang et al.8201616 studies8141 patientsEarly surgery vs. non-early surgery. Early surgery was defined during initial hospitalization before the completion of a full therapeutic course of antibioticsEarly surgery was associated with lower in-hospital and long-term mortality compared with non-early surgical treatment for IE, especially in native valves. Optimal timing remain unclear
Chatterjee et al.9201310 studies3758 patientsEarly surgery with conventional or conservative medical therapy in patients with IE. Early surgery was defined as surgical intervention with valve repair or replacement within 18 days of IE diagnosis, or during initial hospitalizationEarly surgery in patients with IE may be beneficial for long-term survival

IE: infective endocarditis.

Meta-analyses about early surgery vs. late surgery or medical treatment in endocarditis IE: infective endocarditis. These two case reports also highlight the role of multi-modality imaging in patients with IE and raises the question of appropriate timing for follow-up in cases of uncomplicated IE. Both transthoracic and TOE are first-line diagnostic tools which are important in the diagnosis and monitoring regarding progression of IE, and provide information on the features of the lesion and allow characterization of the extent of damage to associated cardiac structures, i.e. simple vegetation vs. abscess or fistula. In the case of aortic root abscesses, pseudo-aneurysms or fistulae, particular in the context of IE involving prosthetic valves where echo imaging may be suboptimal, computed tomography (CT), preferably electrocardiographic gated, has been shown to be non-inferior in terms of sensitivity compared to TOE in achieving the diagnosis. There is also an emerging role for other more novel imaging modalities, i.e. 18FFDG–PET–CT and single-photon emission computed tomography fused with conventional CT. The additional information obtained from this hybrid imaging approaches which integrate the metabolic and anatomic findings allows for more accurate identification of foci of tissue inflammation not available with echo or CT imaging on its own ().
Table 2

Strengths and weaknesses of individual imaging modalities,,,

Imaging modalityStrengthWeakness
Transthoracic echocardiography

Non-invasive

Assessment of valve severity

Visualization of size and mobility of vegetation, perforation

Follow-up of patients on antibiotic therapy and after surgery

No radiation exposure

Difficult differential diagnosis with other masses (thrombi, cusp prolapse, cardiac tumours, myxomatous changes, Lambl’s excrescences, strands, or non-infective vegetations)

Low sensitivity for abscess, pseudo-aneurism or fistulization

Low visualization of mechanical prosthesis, electrodes of devices, intravenous catheter

Transoesophageal echocardiography

No radiation exposure

Better visualization of valve leaflets with lesions characterization and definition of valve severity

Better visualization of valve prosthesis, electrodes of devices, intravenous catheter

Good visualization of root abscess

Intra-operative monitoring of valve surgery

Invasive

Low sensitivity for small abscess or in case of calcification

Acoustic shadowing in case of prosthesis and calcification

18F-fluorodesoxyglucose–positron emission tomography

Detection of enhanced glucose metabolism within organs

Detection of abscess formation and perivalvular extension

Good assessment of prosthetic valves (no acoustic shadowing) and of device infection

Detection of peripheral embolic and metastatic infectious events

Low sensitivity for small oscillating vegetations

Limitation in case of already started antibiotic treatment or in case of slowly evolving infection

Carefully evaluation in recent cardiac valve surgery (post-operative inflammatory response)

Computed tomography scan

Perivalvular extent of abscess and pseudo-aneurism

Root abscess

Good assessment of prosthetic valves

Better evaluation in case of extensive calcification of the valve (no acoustic shadowing)

Assessment of coronary arteries

Detection of silent embolism and extracardiac manifestations/complications

Radiation exposure

Low detection of small vegetation

Not applicable in case of severely impaired renal function

Not applicable in patients with unstable haemodynamics and with iodine allergy

SPECT/CT

Provide exact anatomical localization of the enhanced isotope concentration

Good assessment of prosthetic valves (no acoustic shadowing) and of device infection

Better detection of infectious foci

Radiation exposure

Time consuming

Low-dose contrast is necessary

CT, computed tomography; SPECT, single-photon emission computed tomography.

Strengths and weaknesses of individual imaging modalities,,, Non-invasive Assessment of valve severity Visualization of size and mobility of vegetation, perforation Follow-up of patients on antibiotic therapy and after surgery No radiation exposure Difficult differential diagnosis with other masses (thrombi, cusp prolapse, cardiac tumours, myxomatous changes, Lambl’s excrescences, strands, or non-infective vegetations) Low sensitivity for abscess, pseudo-aneurism or fistulization Low visualization of mechanical prosthesis, electrodes of devices, intravenous catheter No radiation exposure Better visualization of valve leaflets with lesions characterization and definition of valve severity Better visualization of valve prosthesis, electrodes of devices, intravenous catheter Good visualization of root abscess Intra-operative monitoring of valve surgery Invasive Low sensitivity for small abscess or in case of calcification Acoustic shadowing in case of prosthesis and calcification Detection of enhanced glucose metabolism within organs Detection of abscess formation and perivalvular extension Good assessment of prosthetic valves (no acoustic shadowing) and of device infection Detection of peripheral embolic and metastatic infectious events Low sensitivity for small oscillating vegetations Limitation in case of already started antibiotic treatment or in case of slowly evolving infection Carefully evaluation in recent cardiac valve surgery (post-operative inflammatory response) Perivalvular extent of abscess and pseudo-aneurism Root abscess Good assessment of prosthetic valves Better evaluation in case of extensive calcification of the valve (no acoustic shadowing) Assessment of coronary arteries Detection of silent embolism and extracardiac manifestations/complications Radiation exposure Low detection of small vegetation Not applicable in case of severely impaired renal function Not applicable in patients with unstable haemodynamics and with iodine allergy Provide exact anatomical localization of the enhanced isotope concentration Good assessment of prosthetic valves (no acoustic shadowing) and of device infection Better detection of infectious foci Radiation exposure Time consuming Low-dose contrast is necessary CT, computed tomography; SPECT, single-photon emission computed tomography. With regards to appropriate follow-up for cases of uncomplicated IE, the best approach is still unclear. Current clinical practice would typically repeat imaging at least 7 days post-initiation of antibiotic therapy to assess for changes in a patient with IE (both to confirm a possible IE in case of positive blood cultures with initially absence of vegetations or to check for progress and development of complications in IE). However, what makes IE truly insidious is its unpredictability in terms of timing for the development of complications, as demonstrated by both highlighted cases., New trials are still clearly needed to identify potential risk factors which may predict likely progression of IE which could be useful in risk stratification of patients. This in turn would enable us to identify patients most likely to benefit from further investigation or early intervention and thus can help further improve our current management of patients with IE.

Lead author biography

Rita Pavasini is assistant professor and consultant cardiologist at the Cardiology Unit of the University Hospital of Ferrara, Italy. She is responsible for the echocardiographic laboratory, author of more than 80 papers published in high impact factor journals. She participated as investigator in several randomized, multicentre, international clinical trials. Her main field of research are ischemic heart disease and comorbidities (chronic obstructive pulmonary disease), valvular heart disease, cardiac amyloidosis, ischemia reperfusion injury, antiplatelet therapy, percutaneous coronary intervention, frailty in cardiovascular disease. Conflict of interest: None declared. Funding: None declared.
  14 in total

Review 1.  Merits of FDG PET/CT and Functional Molecular Imaging Over Anatomic Imaging With Echocardiography and CT Angiography for the Diagnosis of Cardiac Device Infections.

Authors:  Wengen Chen; Mohammad M Sajadi; Vasken Dilsizian
Journal:  JACC Cardiovasc Imaging       Date:  2018-11

2.  Early surgery reduces mortality in patients with infective endocarditis: insight from a meta-analysis.

Authors:  Saurav Chatterjee; Partha Sardar
Journal:  Int J Cardiol       Date:  2013-05-01       Impact factor: 4.164

3.  Early surgery versus conventional treatment for infective endocarditis.

Authors:  Duk-Hyun Kang; Yong-Jin Kim; Sung-Han Kim; Byung Joo Sun; Dae-Hee Kim; Sung-Cheol Yun; Jong-Min Song; Suk Jung Choo; Cheol-Hyun Chung; Jae-Kwan Song; Jae-Won Lee; Dae-Won Sohn
Journal:  N Engl J Med       Date:  2012-06-28       Impact factor: 91.245

4.  Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis.

Authors:  Kasper Iversen; Nikolaj Ihlemann; Sabine U Gill; Trine Madsen; Hanne Elming; Kaare T Jensen; Niels E Bruun; Dan E Høfsten; Kurt Fursted; Jens J Christensen; Martin Schultz; Christine F Klein; Emil L Fosbøll; Flemming Rosenvinge; Henrik C Schønheyder; Lars Køber; Christian Torp-Pedersen; Jannik Helweg-Larsen; Niels Tønder; Claus Moser; Henning Bundgaard
Journal:  N Engl J Med       Date:  2018-08-28       Impact factor: 91.245

Review 5.  Challenges in Infective Endocarditis.

Authors:  Thomas J Cahill; Larry M Baddour; Gilbert Habib; Bruno Hoen; Erwan Salaun; Gosta B Pettersson; Hans Joachim Schäfers; Bernard D Prendergast
Journal:  J Am Coll Cardiol       Date:  2017-01-24       Impact factor: 24.094

Review 6.  Cardiac imaging in infectious endocarditis.

Authors:  Niels Eske Bruun; Gilbert Habib; Franck Thuny; Peter Sogaard
Journal:  Eur Heart J       Date:  2013-07-30       Impact factor: 29.983

7.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Authors:  Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

Review 8.  Optimal timing for early surgery in infective endocarditis: a meta-analysis.

Authors:  Fuxiang Liang; Bing Song; Ruisheng Liu; Liu Yang; Hanbo Tang; Yuanming Li
Journal:  Interact Cardiovasc Thorac Surg       Date:  2015-12-17

9.  European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Carina Blomström-Lundqvist; Vassil Traykov; Paola Anna Erba; Haran Burri; Jens Cosedis Nielsen; Maria Grazia Bongiorni; Jeanne Poole; Giuseppe Boriani; Roberto Costa; Jean-Claude Deharo; Laurence M Epstein; Laszlo Saghy; Ulrika Snygg-Martin; Christoph Starck; Carlo Tascini; Neil Strathmore
Journal:  Europace       Date:  2020-04-01       Impact factor: 5.214

Review 10.  A management framework for left sided endocarditis: a narrative review.

Authors:  Francesco Nappi; Cristiano Spadaccio; Marc R Moon
Journal:  Ann Transl Med       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.